Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Melittin Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition through Suppression of HIF-1α/Akt Pathway in Liver Cancer.
Chen Q, Lin W, Yin Z, Zou Y, Liang S, Ruan S, Chen P, Li S, Shu Q, Cheng B, Ling C. Chen Q, et al. Among authors: li s. Evid Based Complement Alternat Med. 2019 Apr 1;2019:9602935. doi: 10.1155/2019/9602935. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31057657 Free PMC article.
The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways.
Liang S, Zou Y, Gao J, Liu X, Lin W, Yin Z, Du J, Zhang Y, Chen Q, Li S, Cheng B, Ling C. Liang S, et al. Among authors: li s. Evid Based Complement Alternat Med. 2018 Aug 8;2018:5629304. doi: 10.1155/2018/5629304. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30174709 Free PMC article.
Corrigendum to "The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways".
Liang S, Zou Y, Gao J, Liu X, Lin W, Yin Z, Du J, Zhang Y, Chen Q, Li S, Cheng B, Ling C. Liang S, et al. Among authors: li s. Evid Based Complement Alternat Med. 2022 May 19;2022:9780826. doi: 10.1155/2022/9780826. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35646139 Free PMC article.
100,486 results
You have reached the last available page of results. Please see the User Guide for more information.